Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Pancreatic Neoplasms 29Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Triple Negative Breast Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 8Neoplasm Metastasis 7Esophageal Squamous Cell Carcinoma 7Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ovarian Neoplasms 4Biliary Tract Neoplasms 4Head and Neck Neoplasms 3Gallbladder Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Pancreatic Ductal 3Vaccinia 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms by Site 2Neoplasms 2Locally Advanced Pancreatic Cancer 2Gastrointestinal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Ureteral Neoplasms 1Thyroid Neoplasms 1Squamous Non-small Cell Lung Cancer 1

Interventions

sintilimab 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Salivary Gland Malignant Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT05000892 2022-12-02

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
15 enrolled
Head & NeckOther neoplasm

Salivary Gland Malignant Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡